Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSavannah Resources Regulatory News (SAV)

Share Price Information for Savannah Resources (SAV)

Share Price is delayed by 15 minutes
Get Live Data
6.95    -0.24 (-3.38%)
Bid:
6.80
Ask:
7.10
Spread: 0.30 (4.412%)
Market Cap: £176.68m
SAV Live PriceLast checked at - London Stock Exchange

Intraday Savannah Resources Share Chart

New Corporate Presentation

27 Jul 2022 07:00

RNS Number : 8256T
Savannah Resources PLC
27 July 2022
 

 

27 July 2022

 

Savannah Resources Plc

(AIM: SAV, FWB: SAV and SWB: SAV) ('Savannah', or the 'Company')

 

New Corporate Presentation

 

Savannah Resources plc, the European lithium development company, is pleased to announce that an updated Corporate Presentation will be available today for download on the Company's website at https://www.savannahresources.com/investors/presentations/.

 

 

Savannah -Enabling Europe's energy transition

 

**ENDS**

Follow @SavannahRes on Twitter

Follow Savannah Resources on LinkedIn

 

For further information please visit www.savannahresources.com or contact:

 

Savannah Resources PLC

Dale Ferguson, CEO

 

 

Tel: +44 20 7117 2489

 

SP Angel Corporate Finance LLP (Nominated Advisor)

David Hignell/ Charlie Bouverat

 

 

Tel: +44 20 3470 0470

 

 

finnCap Ltd (Joint Broker)

Christopher Raggett/ Tim Redfern

 

 

Tel: +44 20 7220 0500

 

RBC Capital Markets (Joint Broker)

Farid Dadashev/ Jamil Miah

 

Tel: +44 (0) 20 7653 4000

WH Ireland Limited (Joint Broker)

Jessica Cave/ Ben Good/ Darshan Patel (Corporate Finance)

Aimee McCusker (Corporate Broking)

 

Tel: +44 20 7220 1666

 

 

Camarco (Financial PR)

Gordon Poole/ Emily Hall

Tel: +44 20 3757 4980

 

 

About Savannah

Savannah is the owner of the Barroso Lithium Project, located close to key infrastructure in Northern Portugal which contains the most significant spodumene lithium resource in Western Europe. Following a positive Scoping Study which outlined a conventional operation producing 175,000t of spodumene concentrate per annum, Savannah is progressing the development and environmental licencing of the Barroso Lithium Project.

 

The Company is listed and regulated on AIM and the Company's ordinary shares are also available on the Quotation Board of the Frankfurt Stock Exchange (FWB) under the symbol FWB: SAV, and the Börse Stuttgart (SWB) under the ticker "SAV".

This information is provided by Reach, the non-regulatory press release distribution service of RNS, part of the London Stock Exchange. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.Reach is a non-regulatory news service. By using this service an issuer is confirming that the information contained within this announcement is of a non-regulatory nature. Reach announcements are identified with an orange label and the word “Reach” in the source column of the News Explorer pages of London Stock Exchange’s website so that they are distinguished from the RNS UK regulatory service. Other vendors subscribing for Reach press releases may use a different method to distinguish Reach announcements from UK regulatory news.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
NRAFLFFRDAIRFIF
Date   Source Headline
26th May 20267:00 amRNSExercise of Share Options
21st May 202612:20 pmRNSResult of Annual General Meeting
21st May 20267:00 amRNSAGM Statement
18th May 20267:00 amRNSTechnical work update and first capex purchase
11th May 20267:00 amRNSNotification of Major Shareholding
6th May 202612:30 pmRNSSecond temporary land access granted
1st May 20267:00 amRNSEquity Incentive Plan Awards
21st Apr 20267:00 amRNSInvestor Presentation
17th Apr 20267:00 amRNSHolding(s) in Company
16th Apr 20267:00 amRNSFinancial Results & Notice of AGM
7th Apr 20267:00 amRNSInvestor Presentation
23rd Mar 20267:00 amRNSProject Timetable Update
20th Mar 20267:00 amRNSHolding(s) in Company
26th Feb 20267:00 amRNSProject Update
21st Jan 20267:00 amRNSOfficial signing of the Portuguese State Grant
15th Jan 20267:00 amRNSProject and Market Update
9th Jan 202611:08 amRNSApproval of up to €110m Portuguese State Grant
23rd Dec 20257:00 amRNSChanges To Technical Team
23rd Dec 20257:00 amRNSChanges To Technical Team
19th Dec 20257:00 amRNSAcquisition of Aldeia Mining Lease - Update
19th Dec 20257:00 amRNSAcquisition of Aldeia Mining Lease - Update
12th Dec 20257:00 amRNSRESourceEU Action Plan – Update
4th Dec 20257:00 amRNSReconfirmation of Strategic Project Status
1st Dec 202511:30 amRNS-RSavannah CEO interviewed on Vox Markets
26th Nov 20257:00 amRNSOperational and Sector Update
25th Nov 20257:00 amRNSPurchase of shares by CEO
21st Nov 20257:00 amRNSNotification of Major Shareholding
19th Nov 20257:00 amRNSNotification of Major Shareholding
11th Nov 20253:40 pmRNSResult of RetailBook Offer
11th Nov 20257:00 amRNSInvestor Presentation
7th Nov 20257:40 amRNSInvestor Presentation via Investor Meet Company
7th Nov 20257:26 amRNSResult of Accelerated Bookbuild and Subscription
6th Nov 20255:37 pmRNSRetail Offer
6th Nov 20255:11 pmRNSProposed Fundraise
27th Oct 20257:00 amRNS-RMoU with local healthcare group
23rd Oct 20257:00 amRNSParticipation in trade delegations to Japan
21st Oct 20257:00 amRNSDismissal of Legal Claim
7th Oct 20257:01 amRNSBoard Changes
7th Oct 20257:00 amRNSNotification of Major Shareholding
29th Sep 20257:00 amRNSEquity Incentive Plan – Update
29th Sep 20257:00 amRNSChange of Registered Office
24th Sep 20257:00 amRNSInterim Results for six months ending 30 June 2025
23rd Sep 20258:55 amRNS-RInvestor Presentation
15th Sep 20257:00 amRNSBarroso Lithium Project - JORC Resource Update
4th Sep 20257:04 amRNSProject Update
21st Aug 20257:00 amRNSFinal Assays for Updated Resource Estimates
28th Jul 20257:00 amRNSEquity Incentive Plan
28th Jul 20257:00 amRNSInvestor Presentation
24th Jul 20257:00 amRNSAppointment of Project Finance Advisor
10th Jul 20257:02 amRNSInvestor Presentation

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.